Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Completed × Aspirin × Clear all

Phase

Phase 2 17 Phase 3 8 Phase 1 5 Phase NA 4 Phase EARLY_PHASE1 4 Phase 2/3 4 Phase 1/2 2 Phase 4 1

Status

Unknown 3 Not yet recruiting 2 Terminated 1 Enrolling by invitation 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Barrett Esophagus 1

Interventions

Metformin 23 Saline Solution 22 Zoledronic Acid 21 Dexamethasone 19 Cytarabine 18 Cyclophosphamide 18 Bupivacaine 16 Propofol 15 Sodium Chloride 14 Morphine 14 Methotrexate 14 Letrozole 14 Vincristine 13 Fentanyl 13 Dexmedetomidine 13 Imiquimod 12 Docetaxel 12 Prednisolone 11 Mercaptopurine 11 Doxorubicin 11 Oxycodone 10 Everolimus 10 Capecitabine 10 Bevacizumab 10 Acetaminophen 10 nilotinib 9 enzalutamide 9 Ropivacaine 9 Rituximab 9 Lidocaine 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00637988 2011-01-21

Barrett's Esophagus - 315 - 3 Way Cross Over

AstraZeneca

Phase 4 Completed

Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡